Will Revamped Reimbursement Policies Affect European Injectable Drug Delivery Market

Drug delivery techniques are an inseparable part of medical science. This technology incorporates several different methods and anatomic ways for introducing the drugs into the body. Systematic combination of these techniques and formulations is crucial for the desired effect of the medicines, which makes it all the more essential. Injectable drugs are delivered with help of infusion method, which helps delivering the desired solution into the human body. European injectable drug deliver market is highly competitive and constantly evolving. Increasing demands are driving the market, which is poised to make its mark on global business scenario.



Segmentation in the Market

Based on the countries, Europe’s market is divided into seven sub-segments, which include UK< Germany, Spain, Italy, France, Russia and Rest of the Europe. European injectable drug delivery market is segmented based on the drug delivery methods, technologies and therapeutics. Although the basic segmentation in the market is based on the drug delivery devices and formulations, there is great sub-segmentation based on the therapeutics and products used for injection. Following is the detailed segmentation based on the products in this industry:

  • Implantable
    • Brachytherapy seeds
    • Contraceptive implants
    • Drug eluting stents
    • Implantable infusion pumps
  • Injectable
    • Conventional Injection Devices
      • Fillable Syringes
      • Prefilled Syringes
    • Self-injection Devices
      • Auto-injectors or Safety Syringe Devices
      • Needle-free Injectors
      • Pen Injectors
  • Nasal
    • Nasal drops
    • Nasal inhalers
    • Nasal sprays
  • Ocular
    • Eye drops
    • Gels and ointments
  • Oral
    • Controlled release
    • Orodispersible tablets or ODT
    • Taste masking
  • Pulmonary
    • Dry powder inhalers
    • Metered dose inhalers
    • Nebulizers
  • Topical
    • Liquid formulations
    • Semi-solid formulations
    • Solid formulations
  • Transdermal
    • Active
      • Iontophoresis
      • Microporation
    • Passive
      • Matrix system
      • Reservoir system
  • Transmucosal
    • Buccal and Sublingual
    • Rectal and vaginal

Market Trends and Forecasting Reports

Growing elderly population is increasing the demand for drug and home healthcare services. increasing incidences of patent expiration on blockbuster drugs is also a major driver for the European market. these three driver are forcing the market towards innovation and technological advancements in terms of effectiveness of the drugs and advanced delivery methods. All these efforts by the businesses have a strong governmental backing. Governments and non-governmental organizations across Europe are focusing on health issues of children and elderly, which is evident from recent medical reforms and reimbursement policies. All these factors are influencing the growth of European injectable drug delivery market.

Based on the latest marketing research reports for this industry, the market is anticipated to grow at the CAGR of 12.4%. At this rate, the market will reach $12.4 billion at the end of 2017. As of 2012, the market was worth $6.8 billion in 2012.

Mr. Rohan
North – Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-6006-441
Email: sales@marketsandmarkets.com
Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on Blogspot MarketsandMarkets RSS Feeds

Share this post:

Recent Posts

Comments are closed.